COMPANY PROFILE

AGY Therapeutics

Explore full profile

A South San Francisco, Calif -based biopharmaceutical company

South San Francisco, United StatesFounded 1998Biotech & Life Sciences

Valuation $50–100M Last recorded · 2004

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

At a glance

Status: Operational
Founded: 1998
Headquarters: South San Francisco, United States
Employees: 1
Open positions: None listed
Dealroom signal: 56.4/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Founder mafia, market maps, research and news connected to this company by Dealroom

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	Aug 2004	$9M	$36M	Gimv · GE Capital · Novartis Venture Fund · HBM Partners	—
SERIES B✓Equity / VC	May 2001	$13M	$52M	Lombard Odier · JIF Capital · Alta Partners · Forward Ventures	—

AGY Therapeutics website traffic

Latest recorded traffic for AGY Therapeutics is 0 monthly website visits. AGY Therapeutics's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%

Monthly website visitsOct 2017–Oct 2020

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational	53	$47M	$160M
PGProbably GeneticProbably Genetic helps rare genetic disease patients get diagnosed	San Francisco, United States	Operational
SGSembiosys GeneticsLeveraging its unique proprietary platform to manufacture high-value proteins and oils	Calgary, Canada	Operational
MBMediphage BioceuticalsCures for chronic diseases	Toronto, Canada	Operational
IIIntegene InternationalPrivately held florida corporation	Miami, United States	Closed
CTCultivation TechnologiesInfrastructure, genetics, technology, and branding to the legal medical cannabis industry	Irvine, United States	Operational
BIBioelectronicaA research-stage biotechnology company building next-generation digital tools for drug discovery, diagnostics, and cell sorting	Reno, United States	Operational
PEPeriphaGenA biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector	Pittsburgh, United States	Operational